CENTAURI THERAPEUTICS

centauri-therapeutics-logo

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases. The Alphamer technology is based on "programmable immunity" in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens to fight the infection. The molecules have two distinct parts: one end binds a cell-surface target on the pathogen using an aptamer whereas the other end presents specific epito... pes that attach to the circulating antibodies. It has been demonstrated that Alphamers have the potential to redirect pre-existing antibodies to bacteria in a specific manner and trigger an immediate antibacterial immune response, so clearing the infection. Centauri Therapeuticsโ€™ strategy is to redirect naturally occurring antibodies to target disease. Centauri Therapeutics' unique Chemistry Platform provides a flexible scaffold to enable the synthesis of specific Alphamers. These are bifunctional molecules which present a selective cell binding moiety as well as an epitope that recruits pre-existing antibodies, resulting in cell killing. Centauri Therapeutics believes their technology is widely applicable in the treatment of life threatening infectious diseases. Companies with an interest in accessing Centauriโ€™s Alphamer technology or with an interest in one of their current projects, are warmly encouraged to contact them to discuss partnering opportunities. In order to drive success in the important area of immuno-oncology, Centauri Therapeutics has established a joint venture, Avvinity Therapeutics, with Horizon Discovery in March 2016. Avvinity combines Centauriโ€™s Alphamer Technology with the gene editing and oncology expertise of Horizon. In addition to Centauri Therapeutics' immuno-oncology joint venture, Centauri maintains a strong network of collaborators in the areas of aptamer selection, drug discovery, chemistry and immunology.

#SimilarOrganizations #People #Financial #Website #More

CENTAURI THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Health Care Medical Therapeutics

Founded:
2015-01-01

Address:
Sandwich, Kent, United Kingdom

Country:
United Kingdom

Website Url:
http://www.centauritherapeutics.com

Total Employee:
11+

Status:
Active

Contact:
+44 (0) 1304 728610

Email Addresses:
[email protected]

Total Funding:
42.61 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

1859-logo

1859

1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

animal-dynamics-logo

Animal Dynamics

Animal Dynamics is a spinout company from the Department of Zoology at University of Oxford

apeiron-biologics-logo

Apeiron Biologics

Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.

aro-biotherapeutics-logo

Aro Biotherapeutics

Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines.

effector-therapeutics-logo

Effector Therapeutics

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

genomics-logo

Genomics

Genomics plc aiming to lead the genomic transformation of healthcare.

gyroscope-therapeutics-logo

Gyroscope Therapeutics

Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.

heartbeatbio-logo

HeartBeat.bio

HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.

hummingbird-bioscience-logo

Hummingbird Bioscience

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

innovative-cellular-therapeutics-logo

Innovative Cellular Therapeutics

Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.

merus-logo

Merus

Merus is a biomedical company engaged in the discovery and development of antibody-based biopharmaceuticals.

moderna-therapeutics-logo

Moderna Therapeutics

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

neocodex-logo

NeoCodex

NeoCodex is a human genetics-based biotechnology company specialized in providing biomaterials, analysis, and project development services.

neogene-therapeutics-logo

Neogene Therapeutics

Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.

orchard-therapeutics-logo

Orchard Therapeutics

Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

saga-diagnostics-logo

SAGA Diagnostics

Liquid biopsy testing specialists. Ultrasensitive cancer diagnosis and monitoring to 0.001% variant frequency.

vectivbio-logo

VectivBio

VectivBio is a biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases.


Current Advisors List

clive-dix_image

Clive Dix Chairman of the Board of Directors @ Centauri Therapeutics
Board_member
2016-01-01

camilla-petrycer-hansen_image

Camilla Petrycer Hansen Board Member @ Centauri Therapeutics
Board_member
2022-02-01

mike-westby_image

Mike Westby Member of the Board of Directors @ Centauri Therapeutics
Board_member
2015-09-01

sebastian-kreuz_image

Sebastian Kreuz Board Observer @ Centauri Therapeutics
Board_observer
2022-02-01

jermey-biggs_image

Jermey Biggs Member of the Board of Directors @ Centauri Therapeutics
Board_member

not_available_image

Karen Lackey Board Member @ Centauri Therapeutics
Board_member
2022-02-01

not_available_image

Johannes Zanzinger Board Member @ Centauri Therapeutics
Board_member
2022-02-01

Current Employees Featured

nick-higgins_image

Nick Higgins
Nick Higgins Independent Consultant @ Centauri Therapeutics
Independent Consultant

stuart-lawson_image

Stuart Lawson
Stuart Lawson Founder @ Centauri Therapeutics
Founder

stuart-lawson_image

Stuart Lawson
Stuart Lawson CFO @ Centauri Therapeutics
CFO
2015-03-01

mike-westby_image

Mike Westby
Mike Westby CEO @ Centauri Therapeutics
CEO
2015-09-01

Founder


stuart-lawson_image

Stuart Lawson

Acquisitions List

Date Company Article Price
2016-01-22 Alphamer technology Alphamer technology acquired by Centauri Therapeutics N/A

Investors List

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Centauri Therapeutics

kent-life-science-llp_image

Kent Life Science LLP

Kent Life Science LLP investment in Series A - Centauri Therapeutics

evotec-inc_image

Evotec

Evotec investment in Series A - Centauri Therapeutics

wren-capital_image

Wren Capital

Wren Capital investment in Series A - Centauri Therapeutics

animatrix-founders_image

Animatrix Founders

Animatrix Founders investment in Series A - Centauri Therapeutics

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series A - Centauri Therapeutics

carb-x_image

CARB-X

CARB-X investment in Grant - Centauri Therapeutics

renaissance-capital-partners_image

Renaissance Capital Partners

Renaissance Capital Partners investment in Convertible Note - Centauri Therapeutics

renaissance-capital-partners_image

Renaissance Capital Partners

Renaissance Capital Partners investment in Convertible Note - Centauri Therapeutics

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Centauri Therapeutics

Official Site Inspections

http://www.centauritherapeutics.com Semrush global rank: 8.73 M Semrush visits lastest month: 261

  • Host name: 232.96.189.35.bc.googleusercontent.com
  • IP address: 35.189.96.232
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Centauri Therapeutics" on Search Engine